Results

Total Results: 1,225 records

Showing results for "description".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/tinnitus_research-protocol.pdf
    February 22, 2012 - Was there a description of withdrawals and dropouts? … a) yes, with independent validation* b) yes, eg record linkage or based on self-reports c) no description … 4) Definition of Controls a) no history of disease (endpoint)* b) no description of source … provided of those lost) * c) follow up rate < ____% (select an adequate %) and no description of those … Prognostic factors - A clear description of a prognostic factors measured is provided.
  2. effectivehealthcare.ahrq.gov/sites/default/files/use_of_handheld_mittman_respondent.pdf
    January 01, 2009 - Mittman_Respondent_Ebell 2   Source:    Eisenberg  Center  Conference  Series  2009,  Translating  Information  Into  Action:  Improving  Quality  of   Care  Through  Interactive  Media,  Effective  Health  Care  Program  Web  site   (http://www.effectivehealthcare.…
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research.pdf
    March 01, 2018 - primary outcomes 3 Description of secondary outcome Analysis Description of the pre-specified … Description of the Identified Studies Question 2. … Description of Incomplete or Discontinued Trials Question 4. … Description of the Identified Studies Question 2. … Description of the Identified Studies Question 2.
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ems-911-workforce-mental-health-disposition-comments.pdf
    February 28, 2025 - If the goal is to have this report used by people in the EMS industry, could a simplified description … Peer Reviewer #2 Discussion/ Conclusion Suggestion: Highlight the inclusion/exclusion criteria description … It’s covered in the chart on p.7 but the description here is of added value (p.94, 97). … We have moved the description of EMS population to the Methods section (after we introduce the eligibility … As noted above, we have moved the description to the Methods section. 48 Peer Reviewer #2 Discussion
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/organization-cancer-care-disposition-comments.pdf
    June 20, 2023 - Further description regarding why the Integrated Framework was chosen for evaluation would be worthwhile … Page 2, line 47, begins a description of the Framework's development and the literature that informed … We appreciated your description of the frameworks and have incorporated that text, as well. 23 … This a clear and comprehensive description of the problem, the process, and the findings. … Its description of the literature, as organized by the guiding questions, is well executed and I have
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/prevent-hai-protocol.pdf
    April 16, 2024 - Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description … Sample Search Strategy Embase and MEDLINE in Embase.com Syntax Line # Description Search String #1 … OR (oxygen NEAR/3 humidifier*) OR (pneumatic NEAR/3 tourniquet*) OR (room* NEAR/3 8 Line # Description … *):ti OR ((cohort* OR experimental OR observational) NEAR/2 (stud* OR trial)):ti 9 Line # Description
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/bundled-payments-quality-effects_disposition-comments.pdf
    August 24, 2012 - In the results section, we include a description of each reviewed bundled payment program, including … a description of the bundle definition. … introduction of Case Mix Groups (CMGs) to a description of CMGs. … In the introduction, we added a description of cost- based and fee-for-service payment methods and … We added a description of PROMETHEUS and several other current programs in the results section.
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0278_03-10-2008.pdf
    January 01, 2008 - Topic Description Nominator: Public payer Nomination Summary: The nominator questions the
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0277_03-10-2008.pdf
    January 01, 2008 - Topic Description Nominator: Public payer Nomination Summary: The nominator asks for which
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0074_03-10-2009.pdf
    January 01, 2009 - Topic Description Nominator: Individual Nomination Summary: The nominator is interested
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_overview.pdf
    January 17, 2014 - Topic Description Key Questions: Key Question 1.
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0283_03-10-2008.pdf
    January 01, 2008 - Topic Description Nominator: Public payer Nomination Summary: The nominator suggests there
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0215_01-06-2010.pdf
    January 01, 2010 - Topic Description Nominator: Individual Nomination Summary: The nominator questions whether
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0086_04-01-2009.pdf
    January 01, 2009 - Topic Description Nominator: Individual Nomination Summary: The nominator is interested
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0030_06-19-2008.pdf
    January 01, 2008 - Topic Description Nominator: Government agency Nomination Summary: The nominator questions
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND__0355_09-22-2010.pdf
    January 01, 2010 - Topic Description Nominator: Anonymous individual Nomination Summary: The nominator questions
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0520-131115.pdf
    May 29, 2025 - Topic Description Nominator(s): Organization Nomination Non-invasive Tests to Diagnose Patients
  18. effectivehealthcare.ahrq.gov/sites/default/files/mental-illness-disparities_disposition-comments.pdf
    May 26, 2016 - Comment Response Peer Reviewer #1 Findings I also thought that more information was needed on the description … We rearranged the report structure to add a description of the findings to the beginning of the result … We have included a description of and a citation for the DECIDE study in the “Future Areas for Research … Peer Reviewer #2 Background The Background was thorough in its description of the clinical problem … Peer Reviewer #4 Methods “Systematic review” may not be the most appropriate description of this
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
    September 01, 2011 - However, a description of meta-analysis goes beyond this report. … The description of industry funding has been removed. … The description of industry funding has been removed. … However, there was an error in the description of second study that has been corrected. … However, the description of methotrexate has been expanded.
  20. effectivehealthcare.ahrq.gov/sites/default/files/ch_3-user-guide-to-ocer_130129.pdf
    September 21, 2012 - in subgroups; availability of strong a priori biological and epidemiological evidence; detailed description … endpoints related to outcomes, prespecification of hypotheses relating to subgroup effects, and detailed description

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: